A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.
about
Human Metapneumovirus: lessons learned over the first decadeStructure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic siteHuman metapneumovirus in adultsDiscovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F GlycoproteinEffects of aging on the adaptive immune response to respiratory virus infections.Humoral immunity to human metapneumovirus infection in adultsHuman metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.Soluble recombinant human metapneumovirus G protein is immunogenic but not protective.Small Animal Models for Human Metapneumovirus: Cotton Rat is More Permissive than Hamster and Mouse.A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus.Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.Human metapneumovirus Induces Reorganization of the Actin Cytoskeleton for Direct Cell-to-Cell Spread.The human metapneumovirus fusion protein mediates entry via an interaction with RGD-binding integrins.Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirusBreaking in: human metapneumovirus fusion and entryA live attenuated human metapneumovirus vaccine strain provides complete protection against homologous viral infection and cross-protection against heterologous viral infection in BALB/c mice.Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c miceHuman metapneumovirus in the preterm neonate: current perspectivesNew Approaches for Immunization and Therapy against Human MetapneumovirusHuman metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review.Modulation of Host Immunity by the Human Metapneumovirus.Genetic diversity and evolution of human metapneumovirus fusion protein over twenty yearsThe cotton rat (Sigmodon hispidus) as an animal model for respiratory tract infections with human pathogens.Characterizing Antibodies.Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins.Human metapneumovirus - what we know now.
P2860
Q26822938-68A6B4D3-D58F-4AED-9B80-229FB1247364Q27677823-C425FA21-4B8A-44C3-841D-5FD36AA6A07FQ27694039-6FD8A22B-D641-4842-9ACB-5DD0373EBBE2Q28552644-AA2EFA45-450B-4D9F-A577-D784939B1B35Q33655089-5FD4C928-4790-4C7A-BC67-53A6EA2C80D9Q33830543-86608654-A8A7-4074-ADD0-77CA67F286B0Q33887642-713A8D0A-0775-4953-A588-53452BC2F772Q33950358-0EE2EF45-1353-4F47-A1B5-58724222F090Q34569141-9921F0EC-ABED-4C5D-8E67-60F2B9BDFF9AQ35127300-30255CED-CD9D-44A6-A3D9-AA73C78A2C28Q35913925-985A3A67-1FE9-4BD0-A34A-293FB08F5524Q36023082-F0EAC217-3F71-4BB8-8393-DFCF4B030207Q36147578-5BB7D0E8-FF21-45F3-80FF-067FCFAA6292Q36363922-CC15809C-3803-4544-86C1-9AC710B185B2Q36422618-F63E9B18-ABA8-4E1E-AA29-3EEB1323F298Q36586874-EE2DABB2-FC72-43C7-9F71-3C9B1C41F39DQ37124759-00D593FD-3144-45FE-AC93-A02E563E04C6Q37127953-97D8CCCB-437F-4C49-90AF-AC0B935436D6Q37432520-A6EFADBF-6C3B-4656-95B2-5BFA02C92575Q38524373-2083C8F8-F377-415D-ABCE-2931CFD494DCQ38853701-C33B41B4-3A71-4243-AE84-C97A969FAD99Q38896046-439F5CD5-6E69-493E-93F8-ACF47E8A70D9Q42571145-A224E30E-83F6-4301-8B36-1080E9528E57Q43788138-7F598807-C8AD-4BD9-AEA4-B3A79BC98EEFQ50221364-9DBB37B9-4C9F-473B-A456-02B9483DF08CQ50422323-2216E16E-E10A-487B-85DE-9E05394E0FF0Q55012068-43ADA394-CC6D-4C72-9DEF-82DD9DC32EB9
P2860
A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A recombinant human monoclonal ...... ctive therapeutically in vivo.
@ast
A recombinant human monoclonal ...... ctive therapeutically in vivo.
@en
A recombinant human monoclonal ...... ctive therapeutically in vivo.
@nl
type
label
A recombinant human monoclonal ...... ctive therapeutically in vivo.
@ast
A recombinant human monoclonal ...... ctive therapeutically in vivo.
@en
A recombinant human monoclonal ...... ctive therapeutically in vivo.
@nl
prefLabel
A recombinant human monoclonal ...... ctive therapeutically in vivo.
@ast
A recombinant human monoclonal ...... ctive therapeutically in vivo.
@en
A recombinant human monoclonal ...... ctive therapeutically in vivo.
@nl
P2093
P2860
P356
P1433
P1476
A recombinant human monoclonal ...... ctive therapeutically in vivo.
@en
P2093
Amy Podsiad
Ann Hessell
Bryan E Shepherd
Christopher J Keefer
David W Wright
Dennis R Burton
Gabriella Cseke
Pietro Paolo Sanna
R Anthony Williamson
Sharon J Tollefson
P2860
P304
P356
10.1128/JVI.00106-07
P577
2007-05-23T00:00:00Z